Асосий контентга ўтиш
AkademIndex

Маҳсулотлар

Ишлаб чиқувчилар учун

AkademBaseЭкотизим учун очиқ API
← Ишга қайтиш

Ушбу ишга иқтибос қилган ишлар

7 та иш

Иш: The blockade of immune checkpoints in cancer immunotherapy

  1. Innovations in cancer immunotherapy: A comprehensive overview of recent breakthroughs and future directions

    Chou‐Yi Hsu, Harikumar Pallathadka, Saade Abdalkareem Jasim +7

    Шарҳ мақолаCAR-T cell therapy researchCritical Reviews in Oncology/Hematology20240 иқтибос
    ABI

  2. Molecular dynamics insights into the redox effects on PD-1/PD-L1 and PD-1/PD-L2 interactions

    Rasulbek Mashalov, Zulfizar Toshpulatova, Zhitong Chen +1

    МақолаPlasma Applications and DiagnosticsScientific Reports20250 иқтибос
    ABI

  3. Enhancing Immune Cell Activation through Cold Atmospheric Plasma: Disruption of PD-1/PD-L1/PD-L2 Immune Checkpoints via Molecular Dynamics

    Mashalov Rasulbek, Zulfizar Toshpulatova, Zhitong Chen +1

    ПрепринтPlasma Applications and DiagnosticsbioRxiv (Cold Spring Harbor Laboratory)20250 иқтибос
    ABI

  4. The role of TLRs (microbe recognition receptor) in gastric cancer: An update

    Saade Abdalkareem Jasim, Sumaya Ayad Abdulrazzaq, H. Malathi +7

    Шарҳ мақолаHelicobacter pylori-related gastroenterology studiesNaunyn-Schmiedeberg s Archives of Pharmacology20250 иқтибос
    ABI

  5. CTLA-4: a promising immunosuppressive immune checkpoint in prostate cancer therapy

    Nada Khairi Younis, Ali Fawzi Al-Hussainy, S. Renuka Jyothi +7

    МақолаCancer Immunotherapy and BiomarkersClinical & Translational Oncology20260 иқтибос
    ABI

  6. Overcoming conditional immune resistance in MSS and pMMR colorectal cancer: A sequential gating framework for immunotherapy

    Husni Farah, Djamila Polatova, Jasur Rizaev +5

    МақолаCancer Immunotherapy and BiomarkersCritical Reviews in Oncology/Hematology20260 иқтибос
    ABI

  7. Liposomes containing histidine overcome poly ADP-ribose polymerase inhibitor resistance

    Jing Zhang (23775), Muhammad Tufail, Yun Deng +11

    МақолаPARP inhibition in cancer therapyDrug Resistance Updates20260 иқтибос
    ABI